Last reviewed · How we verify

NCT04876105

Treatment Preferences in Patients With Low Back Pain

Completed Last updated 27 January 2022
What this trial tests

trial testing Assesment of treatment preference in Low Back Pain in 155 participants. Completed in 15 October 2021.

Timeline
25 November 2020
Primary endpoint
30 April 2021
15 October 2021

Quick facts

Lead sponsorPamukkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment155
Start date25 November 2020
Primary completion30 April 2021
Estimated completion15 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 18 to 65, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Together with the guidance of health professionals try to obtain information from media, popular magazines and books and the internet regarding diseases and treatment methods in patients with low back pain with the development of technology. In parallel with this information which they obtained, they turn to different treatment methods. This study was carried on examining how pain duration affects treatment preferences in patients with low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04876105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing